Mixture of liver and kidney associated with lamivudine of hepatitis B glomerulonephritis 33 Patients.doc

 PAGE \* MERGEFORMAT 7 Mixture of liver and kidney associated with lamivudine of hepatitis B glomerulonephritis 33 Patients Of: Zhang Wenjie Maowei Wu Yan Xuan Qu Gong Tian Shuju the Horizontal Extension [Abstract] observed liver mixture with lamivudine of hepatitis B associated glomerulonephritis (HBV GN clinical efficacy. [Method] 63 patients were randomly divided into two groups, control group of 30 patients given lamivudine given oral anti- viral treatment, the treatment group 33 patients in the control group based on the use of Chinese medicine treatment of liver mixture. relevant indicators before and after treatment were observed changes in liver and kidney adverse reaction mixture. [Results] The total effective rate was 90.9%, not adverse effects were found in the control group, the total effective rate was 70.8%, the two groups, the difference was significant in improving the relevant indicators, the two groups, there are significant differences. [Conclusion] mixture with lamivudine on liver and kidney The exact effect of hepatitis B virus associated glomerulonephritis. [Keywords:] hepatitis, nephritis, kidney mixture 8 years in our hospital pathology diagnosed by renal biopsy in 33 cases (HBV GN were treated with combination therapy in Western medicine to achieve better clinical efficacy, reports are summarized below. 1 Clinical data 1.1 General Information All patients were outpatients and inpatients from randomly divided into treatment group and control group. Treated 33 patients, 26 males and 7 females; aged 16 to 55 years (mean 29.4 9.6 years old. Control group of 30 patients, 24 males and 6 females; aged 18 to 59 years (mean age 30.5 + -8.2 .63 patients underwent renal biopsy, in which 26 patients with membranous nephropathy, mesangial proliferative glomerulonephritis in 18 cases , mesangial proliferative glomerulonephritis in 11 cases, focal segmental glomerular sclerosis in 5 cases, 3 cases of sclerosing glomerulonephritis